• Anderson, J.R., Armitage, J.O. & Weisenburger, D.D. (1998) Epidemiology of the non-Hodgkin's lymphomas: distributions of the major subtypes differ by geographic locations. Non-Hodgkin's Lymphoma Classification Project. Annals of Oncology, 9, 717720.
  • Dave, S.S., Wright, G., Tan, B., Rosenwald, A., Gascoyne, R.D., Chan, W.C., Fisher, R.I., Braziel, R.M., Rimsza, L.M., Grogan, T.M., Miller, T.P., LeBlanc, M., Greiner, T.C., Weisenburger, D.D., Lynch, J.C., Vose, J., Armitage, J.O., Smeland, E.B., Kvaloy, S., Holte, H., Delabie, J., Connors, J.M., Lansdorp, P.M., Ouyang, Q., Lister, T.A., Davies, A.J., Norton, A.J., Muller-Hermelink, H.K., Ott, G., Campo, E., Montserrat, E., Wilson, W.H., Jaffe, E.S., Simon, R., Yang, L., Powell, J., Zhao, H., Goldschmidt, N., Chiorazzi, M. & Staudt, L.M. (2004) Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. The New England Journal of Medicine, 351, 21592169.
  • Ganti, A.K., Weisenburger, D.D., Smith, L.M., Hans, C.P., Bociek, R.G., Bierman, P.J., Vose, J.M. & Armitage, J.O. (2006) Patients with grade 3 follicular lymphoma have prolonged relapse-free survival following anthracycline-based chemotherapy: the Nebraska Lymphoma Study Group Experience. Annals of Oncology: Official Journal of the European Society for Medical Oncology/ESMO, 17, 920927.
  • Glas, A.M., Kersten, M.J., Delahaye, L.J., Witteveen, A.T., Kibbelaar, R.E., Velds, A., Wessels, L.F., Joosten, P., Kerkhoven, R.M., Bernards, R., van Krieken, J.H., Kluin, P.M., van't Veer, L.J. & de Jong, D. (2005) Gene expression profiling in follicular lymphoma to assess clinical aggressiveness and to guide the choice of treatment. Blood, 105, 301307.
  • Hans, C.P., Weisenburger, D.D., Vose, J.M., Hock, L.M., Lynch, J.C., Aoun, P., Greiner, T.C., Chan, W.C., Bociek, R.G., Bierman, P.J. & Armitage, J.O. (2003) A significant diffuse component predicts for inferior survival in grade 3 follicular lymphoma, but cytologic subtypes do not predict survival. Blood, 101, 23632367.
  • Jaffe, E.S., Harris, N.L., Stein, H. & Vardiman, J.W. (eds.) (2001) World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. IARC Press, Lyon.
  • Kronz, J.D., Westra, W.H. & Epstein, J.I. (1999) Mandatory second opinion surgical pathology at a large referral hospital. Cancer, 86, 24262435.
  • LaCasce, A.S., Kho, M.E., Friedberg, J.W., Niland, J.C., Abel, G.A., Rodriguez, M.A., Czuczman, M.S., Millenson, M.M., Zelenetz, A.D. & Weeks, J.C. (2008) Comparison of referring and final pathology for patients with non-Hodgkin's lymphoma in the National Comprehensive Cancer Network. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 26, 51075112.
  • Lester, J.F., Dojcinov, S.D., Attanoos, R.L., O'Brien, C.J., Maughan, T.S., Toy, E.T. & Poynton, C.H. (2003) The clinical impact of expert pathological review on lymphoma management: a regional experience. British Journal of Haematology, 123, 463468.
  • Manion, E., Cohen, M.B. & Weydert, J. (2008) Mandatory second opinion in surgical pathology referral material: clinical consequences of major disagreements. The American Journal of Surgical Pathology, 32, 732737.
  • Martinez, A.E., Lin, L. & Dunphy, C.H. (2007) Grading of follicular lymphoma: comparison of routine histology with immunohistochemistry. Archives of Pathology & Laboratory Medicine, 131, 10841088.
  • Matasar, M.J., Shi, W., Silberstien, J., Lin, O., Busam, K.J., Teruya-Feldstein, J., Filippa, D.A., Zelenetz, A.D. & Noy, A. (2012) Expert second-opinion pathology review of lymphoma in the era of the World Health Organization classification. Annals of Oncology: Official Journal of the European Society for Medical Oncology/ESMO, 23, 159166.
  • Naqvi, K., Jabbour, E., Bueso-Ramos, C., Pierce, S., Borthakur, G., Estrov, Z., Ravandi, F., Faderl, S., Kantarjian, H. & Garcia-Manero, G. (2011) Implications of discrepancy in morphologic diagnosis of myelodysplastic syndrome between referral and tertiary care centers. Blood, 118, 46904693.
  • National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology (December 20, 2013). Non-Hodgkin's Lymphomas, Version 1.2014. Available at: [accessed 1 February 2014].
  • National Institute for Health and Care Excellence (NICE) (October 22, 2003). Guidance on Cancer Services – Improving Outcomes in Haematological Cancers – The Manual. Available at: [accessed 1 February 2014].
  • Proctor, I.E., McNamara, C., Rodriguez-Justo, M., Isaacson, P.G. & Ramsay, A. (2011) Importance of expert central review in the diagnosis of lymphoid malignancies in a regional cancer network. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 29, 14311435.
  • Swapp, R.E., Aubry, M.C., Salomao, D.R. & Cheville, J.C. (2013) Outside case review of surgical pathology for referred patients: the impact on patient care. Archives of Pathology & Laboratory Medicine, 137, 233240.
  • Swerdlow, S.H., Campo, E., Harris, N.L., Jaffe, E.S., Pileri, S.A., Stein, H., Thiele, J. & Vardiman, J.W. (eds.) (2008) World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues. IARC Press, Lyon.
  • Wahlin, B.E., Yri, O.E., Kimby, E., Holte, H., Delabie, J., Smeland, E.B., Sundstrom, C., Christensson, B. & Sander, B. (2012) Clinical significance of the WHO grades of follicular lymphoma in a population-based cohort of 505 patients with long follow-up times. British Journal of Haematology, 156, 225233.
  • Wang, S.A., Wang, L., Hochberg, E.P., Muzikansky, A., Harris, N.L. & Hasserjian, R.P. (2005) Low histologic grade follicular lymphoma with high proliferation index: morphologic and clinical features. The American Journal of Surgical Pathology, 29, 14901496.
  • Wilkins, B.S. (2011) Pitfalls in lymphoma pathology: avoiding errors in diagnosis of lymphoid tissues. Journal of Clinical Pathology, 64, 466476.